ONiP Logo

Smoking Cessation in People Diagnosed with Lung Cancer


Healthcare professionals, including nurses, play a fundamental role in the smoking cessation journey of patients. Successful smoking cessation can be life-changing for patients, giving them the opportunity to live a longer and improved life. This module has been designed to provide you with an understanding of the relationship between lung cancer and smoking, why smoking cessation is vitally important, and what you can do to encourage and support patients through the smoking cessation process.

While this module focuses on people diagnosed with lung cancer, it contains smoking cessation information that can be applied to any patient who smokes.

Please see our disclaimer regarding module content.

This e-learning module will take you just 60 minutes to complete. Optional pre-reading available in the ‘resources’ section of this page will take approximately 30–60 minutes. Saving where you left off, you can dip in and out of the module whenever you have the time. You are encouraged to take notes and/or save personal screenshots during the module to reinforce your learning.

A certificate is still available to download upon module completion to add to your portfolio, however accreditation received by the Federation of the Royal College of Nursing (RCN) has expired.

Nurses play a key role in the provision of smoking cessation support, which is critical to the lives of many patients.

CPD Module

This module has been developed to provide nurses with a knowledge of the importance and process of smoking cessation in patients diagnosed with lung cancer.

Smoking Cessation in People Diagnosed with Lung Cancer


* Save your place and obtain CME credits.

† Your place will not be saved.


The faculty

Lavinia Magee

Nurse Consultant in Thoracic Oncology Royal Papworth Hospital, Cambridge

Amy Kerr

Lead Thoracic Research Nurse Heartlands Hospital, Birmingham


These independent educational activities have been developed in collaboration with the National Lung Cancer Forum for Nurses and is supported by educational grants provided by Pfizer Inc. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme. The activity is run independently of the financial supporter and all content is created by the faculty. No funder has had input into the content of the activity.